Market Tracker

08/29 3:06am ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.55
Delayed Data
As of Aug 26
 +0.03 / +0.46%
Today’s Change
3.61
Today|||52-Week Range
8.37
+6.85%
Year-to-Date
4 Biotech Stock Charts You Must See
Aug 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.52
Today’s open6.54
Day’s range6.41 - 6.72
Volume1,131,297
Average volume (3 months)1,346,926
Market cap$458.4M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+122.32%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book5.06

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...+1.11+5.49%
OMEROmeros Corp+0.04+0.37%
CXRXConcordia Internatio...-0.09-1.01%
FLXNFlexion Therapeutics...+0.28+1.68%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)$0.55
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts